1. Home
  2. GFAI vs CALC Comparison

GFAI vs CALC Comparison

Compare GFAI & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • CALC
  • Stock Information
  • Founded
  • GFAI 2018
  • CALC 2011
  • Country
  • GFAI Singapore
  • CALC United States
  • Employees
  • GFAI N/A
  • CALC N/A
  • Industry
  • GFAI Diversified Commercial Services
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • GFAI Consumer Discretionary
  • CALC Health Care
  • Exchange
  • GFAI Nasdaq
  • CALC Nasdaq
  • Market Cap
  • GFAI 23.3M
  • CALC 32.4M
  • IPO Year
  • GFAI N/A
  • CALC N/A
  • Fundamental
  • Price
  • GFAI $1.21
  • CALC $3.78
  • Analyst Decision
  • GFAI Strong Buy
  • CALC Strong Buy
  • Analyst Count
  • GFAI 1
  • CALC 2
  • Target Price
  • GFAI $4.50
  • CALC $14.50
  • AVG Volume (30 Days)
  • GFAI 722.9K
  • CALC 132.2K
  • Earning Date
  • GFAI 09-23-2025
  • CALC 08-11-2025
  • Dividend Yield
  • GFAI N/A
  • CALC N/A
  • EPS Growth
  • GFAI N/A
  • CALC N/A
  • EPS
  • GFAI N/A
  • CALC N/A
  • Revenue
  • GFAI $36,347,373.00
  • CALC N/A
  • Revenue This Year
  • GFAI $5.66
  • CALC N/A
  • Revenue Next Year
  • GFAI $4.69
  • CALC N/A
  • P/E Ratio
  • GFAI N/A
  • CALC N/A
  • Revenue Growth
  • GFAI 0.18
  • CALC N/A
  • 52 Week Low
  • GFAI $0.76
  • CALC $1.42
  • 52 Week High
  • GFAI $3.88
  • CALC $5.97
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 46.47
  • CALC 72.28
  • Support Level
  • GFAI $1.27
  • CALC $3.37
  • Resistance Level
  • GFAI $1.48
  • CALC $4.26
  • Average True Range (ATR)
  • GFAI 0.10
  • CALC 0.44
  • MACD
  • GFAI -0.01
  • CALC 0.14
  • Stochastic Oscillator
  • GFAI 19.44
  • CALC 81.95

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: